Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mersana Therapeutics Inc (MRSN)

Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mersana Therapeutics Inc 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 USA

www.mersana.com Employees: 102 P: 617-498-0020

Sector:

Medical

Description:

Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.

Key Statistics

Overview:

Market Capitalization, $K 145,340
Enterprise Value, $K 61,040
Shares Outstanding, K 4,999
Annual Sales, $ 40,500 K
Annual Net Income, $ -69,190 K
Last Quarter Sales, $ 11,010 K
Last Quarter Net Income, $ -7,550 K
EBIT, $ -71,510 K
EBITDA, $ -73,800 K
60-Month Beta 0.45
% of Insider Shareholders 13.00%
% of Institutional Shareholders 93.92%
Float, K 4,349
% Float 87.00%
Short Interest 54
Short Float 1.08%
Short Volume Ratio 0.43

Growth:

1-Year Return -18.10%
3-Year Return -80.15%
5-Year Return -95.63%
5-Year Revenue Growth -3.85%
5-Year Earnings Growth 13.85%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.51 on 11/14/25
Next Earnings Date 03/02/26
Earnings Per Share ttm -13.09
EPS Growth vs. Prev Qtr 62.99%
EPS Growth vs. Prev Year 32.89%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 07/28/25

MRSN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -65.42%
Profit Margin % -170.84%
Debt/Equity 0.00
Price/Sales 3.59
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -11.93
Interest Coverage -16.77
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar